How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
Earlier this week in an opinion piece for the New York Times filmmaker, Angelina Jolie Pitt describes her decision to have her ovaries and fallopian tubes removed. The surgery comes just two years after her choice to have a double mastectomy. Genetic tests had confirmed she carried a mutation in the BRCA gene which put her at greater risk for breast and ovarian cancer. Many doctors say her decision was a good one, but it highlights the kinds of challenges genetic test results can present: Please join us to discuss BRCA test results and efforts to stop breast and ovarian cancers before they start.
- Mary-Claire King Professor of medicine and genome sciences, University of Washington.
- Beth Peshkin Senior genetics counselor, Lombardi Comprehensive Cancer Center and professor of oncology,Georgetown University Medical Center.
- Dr Amanda Nickles Fader Director, Kelly Gynecologic Oncology Service, associate professor of gynecology and obstetrics, Johns Hopkins Medicine.
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.